Myasthenia and neuroborreliosis with excessively high acetylcholine-receptor antibodies

被引：3

作者：

Finsterer, Josef ^{[1
]}

机构：

[1] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria

来源：

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES | 2007年 / 39卷 / 02期

关键词：

D O I：

10.1080/00365540600818029

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

In a 29-y-old male with neuroborreliosis, partially responsive to ceftriaxone, myasthenia gravis with acetylcholine-receptor antibodies elevated almost 1000 times the upper reference limit was diagnosed. Pyridostigmine resolved all remaining neurological deficits. During a 1-y follow-up the patient remained symptom free, despite persistently high acetylcholinereceptor antibodies. They were attributed to epitope homology of the acetylcholine receptors and Borrelia surface antigens.

引用

页码：187 / 190

页数：4

共 12 条

[1] Antigen mimicry in autoimmune disease. Can immune responses to microbial antigens that mimic acetylcholine receptor act as initial triggers of myasthenia gravis? [J].

Deitiker, P ;

Ashizawa, T ;

Atassi, MZ .

HUMAN IMMUNOLOGY, 2000, 61 (03) :255-265

[2] IMMUNOLOGICAL CROSS-REACTIVITY BETWEEN MIMICKING EPITOPES ON A VIRUS PROTEIN AND A HUMAN AUTOANTIGEN DEPENDS ON A SINGLE AMINO-ACID RESIDUE [J].

DYRBERG, T ;

PETERSEN, JS ;

OLDSTONE, MBA .

CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 54 (02) :290-297

[3] Respiratory chain complex-I defect mimicking myasthenia [J].

Finsterer, J ;

Oberman, I ;

Reitner, A .

METABOLIC BRAIN DISEASE, 2002, 17 (01) :41-46

[4]

HOWARD FM, 1987, ANN NY ACAD SCI, V505, P526

[5]

MAPPOURAS DG, 1995, CLIN EXP IMMUNOL, V100, P336

[6] UNEXPECTED CROSS-REACTIVITY BETWEEN MYOSIN AND A MAIN IMMUNOGENIC REGION (MIR) OF THE ACETYLCHOLINE-RECEPTOR BY ANTISERA OBTAINED FROM MYASTHENIA-GRAVIS PATIENTS [J].

MOHAN, S ;

BAROHN, RJ ;

KROLICK, KA .

CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 64 (03) :218-226

[7]

Newsom-Davis J, 2005, ACTA NEUROL BELG, V105, P181

[8] SEARCH FOR CROSS-REACTIVE IDIOTYPES ON MONOCLONAL AND MYASTHENIA-GRAVIS ACETYLCHOLINE-RECEPTOR ANTIBODIES [J].

ROBERTS, A ;

LANG, B ;

VINCENT, A ;

NEWSOMDAVIS, J .

AUTOIMMUNITY, 1992, 12 (01) :53-60

[9] Therapeutic and preventive interventions for postulated vasoactive neuropeptide autoimmune fatigue-related disorders [J].

Staines, DR .

MEDICAL HYPOTHESES, 2005, 65 (04) :797-803

[10]

Tzartos SJ, 1999, CLIN EXP IMMUNOL, V116, P146

← 1 2 →